CML Support Groups: Members of the CML Advocates Network

The CML Advocates Network connects patient organisations supporting patients and families affected with Chronic Myeloid Leukemia (CML)

If your group is not listed here, please register. If details have changed, please contact us.

CML Patient Organisations

Lithuania: Community of Oncohematological Patients (COHP) KRAUJAS

Contact address:

Santariškių g. 2
Vilnius
Vilniaus raj. LT-08661
Lithuania

Telephone: +37068740952

Website: www.kraujas.lt
Email: info@kraujas.lt

Facebook: https://www.facebook.com/kraujas.lt

Key contacts:

Aistė Vadlūgaitė–Strelčiūnė - Communications and project manager
Email: aiste@kraujas.lt
Phone: +37068740952

Brief description of organization:

Since 2002 a non-profit, non-government organization ‘Kraujas’ unites patients with oncohematological diseases, their relatives, medical specialists, and everyone who supports the ideas of its activities, volunteering, and bone marrow and blood donation.

Association ‘Kraujas’ actively participates in health politics in Lithuania, represents oncohematological patients’ needs, speaks out for important issues related to oncohematological diseases, presents concerns that patients are facing, and seeks constructive and effective dialogue between patients and health politics.

Association ‘Kraujas’ seeks to ensure accessibility of psychological support for oncological patients and their relatives. Psychological support is provided for patients during treatment or in remission, recovered patients who are having difficulties returning to the ordinary life rhythm, patients’ relatives as well as people who are experiencing grief and loss.

Audience/Constituency

Oncohematological patients and their relatives; oncological patients and their relatives; medicine specialists.

Organizational objectives and key programs:

Our organizational objectives are:

  • To seek for a constructive and efficient dialogue between patients, physicians and health politicians.
  • To continuously and responsibly educate patients, promote their activity and interest in their disease and modern treatment options.
  • To educate society and legislators on the advances in medicine, eliminate popular stigmata.
  • To support development and advance in oncohematological support.
  • To provide and develop rehabilitation, oncohematologic and social integration of patients with oncohematological, oncological and rare diseases and their relatives.

Year of establishment:

2002

Year of becoming a CML Member:

2011


 
   
 

Please donate!

Please donate!

EU e-Privacy Directive